Sourcebio International PLC
LSE:SBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sourcebio International PLC
LSE:SBI
|
UK |
|
G-Next Inc
TSE:4179
|
JP |
|
Bafang Electric Suzhou Co Ltd
SSE:603489
|
CN |
|
N
|
Nike Inc
SGO:NKE
|
US |
|
N
|
Nichicon Corp
TSE:6996
|
JP |
|
Nagase Brothers Inc
TSE:9733
|
JP |
|
Aurora Solar Technologies Inc
XTSX:ACU
|
CA |
|
S
|
Shanghai Model Organisms Center Inc
SSE:688265
|
CN |
|
Asaka Riken Co Ltd
TSE:5724
|
JP |
|
Lincoln Gold Mining Inc
XTSX:LMG
|
CA |
|
M
|
Melbourne Enterprises Ltd
HKEX:158
|
HK |
|
Shopify Inc
NASDAQ:SHOP
|
CA |
|
A
|
Aplicaciones y Tratamientos de Sistemas SA
MAD:ATSI
|
ES |
|
Japan Exchange Group Inc
TSE:8697
|
JP |
|
Kedawung Setia Industrial Tbk PT
IDX:KDSI
|
ID |
|
N
|
Nike Inc
SWB:NKE
|
US |
|
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
ZA |
|
H
|
Hagar hf
ICEX:HAGA
|
IS |
Sourcebio International PLC
SourceBio International Plc engages in the provision of laboratory services in healthcare, clinical, life science research, and biopharma industries. The company is headquartered in Nottingham, Nottinghamshire. The company went IPO on 2020-10-29. The firm operates through four business segments: Infectious Disease Testing, Healthcare Diagnostics, Genomics and Stability Storage. Its Infectious Disease Testing segment offers COVID-19 antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services to the national health service (NHS), private healthcare providers and private industry. Its Healthcare Diagnostics segment offers histopathology and clinical diagnostic services for the NHS and private healthcare across the United Kingdom and Ireland. Its Genomics segment offers deoxyribonucleic acid (DNA) sequencing services for pharmaceutical and biotechnology companies, academia, contract research organizations (CROs) and other research groups in the United Kingdom, Europe and North America. Its Stability Storage segment offers shelf-life testing services and equipment for pharmaceutical companies and others.
SourceBio International Plc engages in the provision of laboratory services in healthcare, clinical, life science research, and biopharma industries. The company is headquartered in Nottingham, Nottinghamshire. The company went IPO on 2020-10-29. The firm operates through four business segments: Infectious Disease Testing, Healthcare Diagnostics, Genomics and Stability Storage. Its Infectious Disease Testing segment offers COVID-19 antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services to the national health service (NHS), private healthcare providers and private industry. Its Healthcare Diagnostics segment offers histopathology and clinical diagnostic services for the NHS and private healthcare across the United Kingdom and Ireland. Its Genomics segment offers deoxyribonucleic acid (DNA) sequencing services for pharmaceutical and biotechnology companies, academia, contract research organizations (CROs) and other research groups in the United Kingdom, Europe and North America. Its Stability Storage segment offers shelf-life testing services and equipment for pharmaceutical companies and others.
